List & timeline of expected news in 2020

Hello fellow ZLD holders.

Exciting times ahead this year.

Given everything in the works for 2020, I thought I'd post a consolidated list of expected newsflow (that we know of so far) for 2020.

I hope the below proves helpful for any holders unaware of the full scope of the companies activities and 2020 trajectory. Please note that below is not my speculation, but collated from contact with Richard Hopkins directly, and company announcements. Please view the recent Q & A I posted with Richard for your reference.

Are you all as excited as I am?

All the best, Harry


Expected 2020 Newsflow Jan-June

• Insomnia phase II trial results (in the next fortnight).
• Quarterly report detailing maiden revenues (in the next fortnight).
• Opiod sparing report.
• Licensing of HOPE autism formula across additional U.S. states (R. Hopkins: "The strategy in the US will be to license the rights to HOPE to selected manufacturers/distributers in each US-state. Late last year we announced our first licensing deal into Louisiana, which will bring revenues from an upfront fee and royalties on sales. Our plan is to repeat this process for all 34 states where medicinal cannabis has been legalised.")
• Licensing/rollout of HOPE autism formula in ex-US markets.
• Launch of new product for Aged Care.
• Launch of new product for Insomnia, if trial results support this.
• Commencement of clinical trial for Autism, aligned to HOPE product range.
• Comprehensive update on all pre-clinical cancer research.

Expected 2020 Newsflow July-December

• Licensing of HOPE autism formula across additional U.S. states
• Licensing/rollout of HOPE autism formula in ex-US markets.
• Clinical trial launched for Targetted Pain.
• Clinical trial launched for Targeted Gastro-Intestinal disorders.
• Intention to launch new OTC dermatology products.
• Intention to launch new OTC oral health care products.